NEW DELHI: Some of the ingenious methods drug makers adopt to escape price control may no longer work. Drug makers who intentionally make derivatives of a price-controlled drug to escape regulatory attention will soon face a tougher price regulator.
Read More
Thursday, August 23, 2007
NPPA to end one more price dodge by pharmas
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment